2025 Sequencing Strategies for Population and Cancer Epidemiology Studies (SeqSPACE)

Submitted by nusratyj on

2025 SeqSPACE Abstract Submission Form

Thank you for your interest in submitting an abstract for the 2025 Sequencing Strategies for Population and Cancer Epidemiology Studies (SeqSPACE) webinar series. We are interested in highlighting the work of Junior Investigators for our upcoming webinars in Fall/Winter 2025. If you are interested in applying, please fill out the form below. Submissions are due August 29, 5:00 p.m. ET, at which time they will go through a review and selection process by the SeqSPACE Planning Committee.

For the purposes of this series, a Junior Investigator includes upper-level PhD, MD, MD/PhD, DrPH, or students in equivalent degree-related programs and postdocs, as well as early career faculty.

Abstracts will be selected based on the research’s rigor, novelty, potential impact, and relevance to the application of sequencing technologies in population and cancer epidemiology. We also encourage abstracts from projects that leverage existing resources. Final abstract selections will be confirmed to present no later than September 12, 2025, via email. More information on webinar format and logistics will be provided at a later date.

Once you hit Submit, you will receive a confirmation email that will contain a link allowing you to make edits to your submission. For further information or questions, please contact NCISeqSPACE@mail.nih.gov.

Learn more about the SeqSPACE webinar series here: https://epi.grants.cancer.gov/events/seqSPACE/.

 

OMB No.: 0925-0740
Expiration Date: 9/30/2025

Public reporting burden for this collection of information is estimated to average 60 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

Presenter Information

Please enter information for the person who will be the primary presenter/speaker/author.

Please use the following formatting for these degrees: M.D. Ph.D. MPH
Abstract Information
Please limit to 300 words.